Table 2.
Specificity and sensitivity of validated anti-PD-L1 antibodies in FR and FFPE tissues of 30 breast cancer patients.
E1L3N | 28-8 | |||||
---|---|---|---|---|---|---|
FR | FFPE | ↓Drop | FR | FFPE | ↓Drop | |
♣ R. Sensitivity | 67 | 33 | 34 | 89 | 22 | 67 |
R. Specificity | 100 | 100 | 0 | 95 | 100 | 0 |
♣ Sensitivity and specificity are relative to MIH1 reactivity in FR sections.